3-(1-dimethylaminoethyl)phenol,
NAP 226-90,
NAP-226-90,
NAP226-90,
105601-04-5,
3-[1-(dimethylamino)ethyl]phenol,
3-(1-(dimethylamino)ethyl)phenol,
Phenol, 3-[1-(dimethylamino)ethyl]-,
3-(1-(DIMETHYLAMINO)ETHYL]PHENOL,
Phenol,3-[1-(dimethylamino)ethyl]-,
3-(1-DIMETHYLAMINOETHYL)PHENOL,
3-(1-dimethylamino-ethyl)-phenol,
AK-36564,
AK-51758,
Phenol,3-[(1S)-1-(dimethylamino)ethyl]-,
ACMC-209vzk,
AC1L8WWC,
ACMC-209vt2,
SCHEMBL43343,
PHE015,
RA08,
BDBM10630,
CTK4A3955,
DTXSID20328334,
GQZXRLWUYONVCP-UHFFFAOYSA-N,
HMS3604C09,
ANW-45726,
CD-741,
MFCD08272688,
STL450948,
AKOS015850703,
AC-3488,
RTR-001167,
VZ26185,
Rivastigmine metabolite|||NAP 226-90,
AK-32756,
AN-12943,
BC216137,
SC-00998,
SC-13426,
SY067144,
SY102287,
(+/-)-3-(1-(dimethylamino)ethyl)phenol,
AB0057613,
DB-012764,
ST2405189,
TR-001167,
AM20080966,
FT-0642603,
MFCD06656491 (97%),
MFCD08272688 (95%),
3-[1-(Dimethylamino)ethyl]phenol, AldrichCPR,
M-2928,
601D045,
A801275,
I01-0844,
Q-101325,
S01-0174,
3- phenol,
ent NAP 226-90,
3-[(1S)-1-(Dimethylaminoethyl)]phenol,
(S)-3-(1-(dimethylamino)ethyl)phenol,
3-(1-Dimethyl amino ethyl)phenol,
(R)-3-(1-(DIMETHYLAMINO)ETHYL)PHENOL,
CID409441,
3-[1-(Dimethylamino)ethyl]phenol 5g,
NAP-226-90,
(s)-3-[1-(dimethylamino)ethyl]phenol,
139306-10-8,
Phenol, 3-[(1S)-1-(dimethylamino)ethyl]-,
851086-95-8,
5441-61-2,
NAP,
SAF,